CRNX - CIK 0001658247
Crinetics Pharmaceuticals, Inc. has filed 670 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (249 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Passive ownership stake (update) | SC 13G/A | 2023-02-08 | - |
| Passive ownership stake | SC 13G | 2023-02-06 | - |
| Insider trade | 4 | 2023-02-03 | 2023-02-01 |
| Passive ownership stake (update) | SC 13G/A | 2023-01-31 | - |
| Annual insider summary | 5 | 2023-01-27 | 2022-12-31 |
| Annual insider summary | 5 | 2023-01-27 | 2022-12-31 |
| Annual insider summary | 5 | 2023-01-27 | 2022-12-31 |
| Insider trade | 4 | 2023-01-27 | 2023-01-25 |
| Insider trade | 4 | 2023-01-19 | 2023-01-17 |
| Company correspondence | CORRESP | 2023-01-19 | - |
| Major company event | 8-K | 2023-01-09 | 2023-01-09 |
| Insider trade | 4 | 2023-01-05 | 2023-01-03 |
| SEC correspondence | UPLOAD | 2022-12-20 | - |
| Insider trade | 4 | 2022-12-19 | 2022-12-15 |
| Insider trade | 4 | 2022-12-05 | 2022-12-01 |
| Major company event | 8-K | 2022-11-28 | 2022-11-28 |
| Insider trade | 4 | 2022-11-17 | 2022-11-15 |
| Employee stock plan | S-8 | 2022-11-14 | - |
| Quarterly report | 10-Q | 2022-11-14 | 2022-09-30 |
| Major company event | 8-K | 2022-11-14 | 2022-11-14 |
| Insider trade | 4 | 2022-11-03 | 2022-11-01 |
| Insider trade | 4 | 2022-10-19 | 2022-10-17 |
| Insider trade | 4 | 2022-10-14 | 2022-10-12 |
| Major company event | 8-K | 2022-10-13 | 2022-10-13 |
| Insider trade | 4 | 2022-10-11 | 2022-10-10 |
| New insider ownership | 3 | 2022-10-11 | 2022-09-30 |
| Insider trade | 4 | 2022-10-05 | 2022-10-03 |
| Major company event | 8-K | 2022-10-03 | 2022-10-03 |
| Insider trade | 4 | 2022-09-19 | 2022-09-15 |
| Major company event | 8-K | 2022-09-15 | 2022-09-09 |
| Insider trade | 4 | 2022-09-09 | 2022-09-07 |
| Insider trade | 4 | 2022-09-06 | 2022-09-01 |
| Prospectus supplement | 424B5 | 2022-08-12 | - |
| Quarterly report | 10-Q | 2022-08-12 | 2022-06-30 |
| Major company event | 8-K | 2022-08-12 | 2022-08-12 |
| Insider trade | 4 | 2022-07-29 | 2022-07-26 |
| Insider trade | 4 | 2022-07-15 | 2022-07-13 |
| Insider trade | 4 | 2022-06-21 | 2022-06-17 |
| Insider trade | 4 | 2022-06-21 | 2022-06-17 |
| Insider trade | 4 | 2022-06-21 | 2022-06-17 |
| Insider trade | 4 | 2022-06-21 | 2022-06-17 |
| Insider trade | 4 | 2022-06-21 | 2022-06-17 |
| Insider trade | 4 | 2022-06-21 | 2022-06-17 |
| Insider trade | 4 | 2022-06-21 | 2022-06-17 |
| Major company event | 8-K | 2022-06-21 | 2022-06-17 |
| Major company event | 8-K | 2022-05-25 | 2022-05-25 |
| Quarterly report | 10-Q | 2022-05-12 | 2022-03-31 |
| Major company event | 8-K | 2022-05-12 | 2022-05-12 |
| Insider trade | 4 | 2022-05-04 | 2022-05-02 |
| Proxy materials | DEFA14A | 2022-04-28 | - |